292 related articles for article (PubMed ID: 25686088)
1. Structures of CYLD USP with Met1- or Lys63-linked diubiquitin reveal mechanisms for dual specificity.
Sato Y; Goto E; Shibata Y; Kubota Y; Yamagata A; Goto-Ito S; Kubota K; Inoue J; Takekawa M; Tokunaga F; Fukai S
Nat Struct Mol Biol; 2015 Mar; 22(3):222-9. PubMed ID: 25686088
[TBL] [Abstract][Full Text] [Related]
2. The structure of the CYLD USP domain explains its specificity for Lys63-linked polyubiquitin and reveals a B box module.
Komander D; Lord CJ; Scheel H; Swift S; Hofmann K; Ashworth A; Barford D
Mol Cell; 2008 Feb; 29(4):451-64. PubMed ID: 18313383
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for specific cleavage of Lys6-linked polyubiquitin chains by USP30.
Sato Y; Okatsu K; Saeki Y; Yamano K; Matsuda N; Kaiho A; Yamagata A; Goto-Ito S; Ishikawa M; Hashimoto Y; Tanaka K; Fukai S
Nat Struct Mol Biol; 2017 Nov; 24(11):911-919. PubMed ID: 28945247
[TBL] [Abstract][Full Text] [Related]
4. CYLD Limits Lys63- and Met1-Linked Ubiquitin at Receptor Complexes to Regulate Innate Immune Signaling.
Hrdinka M; Fiil BK; Zucca M; Leske D; Bagola K; Yabal M; Elliott PR; Damgaard RB; Komander D; Jost PJ; Gyrd-Hansen M
Cell Rep; 2016 Mar; 14(12):2846-58. PubMed ID: 26997266
[TBL] [Abstract][Full Text] [Related]
5. Regulation of CYLD activity and specificity by phosphorylation and ubiquitin-binding CAP-Gly domains.
Elliott PR; Leske D; Wagstaff J; Schlicher L; Berridge G; Maslen S; Timmermann F; Ma B; Fischer R; Freund SMV; Komander D; Gyrd-Hansen M
Cell Rep; 2021 Oct; 37(1):109777. PubMed ID: 34610306
[TBL] [Abstract][Full Text] [Related]
6. Insights into the mechanism of deubiquitination by JAMM deubiquitinases from cocrystal structures of the enzyme with the substrate and product.
Shrestha RK; Ronau JA; Davies CW; Guenette RG; Strieter ER; Paul LN; Das C
Biochemistry; 2014 May; 53(19):3199-217. PubMed ID: 24787148
[TBL] [Abstract][Full Text] [Related]
7. OTULIN antagonizes LUBAC signaling by specifically hydrolyzing Met1-linked polyubiquitin.
Keusekotten K; Elliott PR; Glockner L; Fiil BK; Damgaard RB; Kulathu Y; Wauer T; Hospenthal MK; Gyrd-Hansen M; Krappmann D; Hofmann K; Komander D
Cell; 2013 Jun; 153(6):1312-26. PubMed ID: 23746843
[TBL] [Abstract][Full Text] [Related]
8. Subquinocin, a small molecule inhibitor of CYLD and USP-family deubiquitinating enzymes, promotes NF-κB signaling.
Yamanaka S; Sato Y; Oikawa D; Goto E; Fukai S; Tokunaga F; Takahashi H; Sawasaki T
Biochem Biophys Res Commun; 2020 Mar; 524(1):1-7. PubMed ID: 31898971
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of an Active-Site Flap Contributes to Catalysis in a JAMM Family Metallo Deubiquitinase.
Bueno AN; Shrestha RK; Ronau JA; Babar A; Sheedlo MJ; Fuchs JE; Paul LN; Das C
Biochemistry; 2015 Oct; 54(39):6038-51. PubMed ID: 26368668
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of recruitment and activation of the endosome-associated deubiquitinase AMSH.
Davies CW; Paul LN; Das C
Biochemistry; 2013 Nov; 52(44):7818-29. PubMed ID: 24151880
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20.
Lin SC; Chung JY; Lamothe B; Rajashankar K; Lu M; Lo YC; Lam AY; Darnay BG; Wu H
J Mol Biol; 2008 Feb; 376(2):526-40. PubMed ID: 18164316
[TBL] [Abstract][Full Text] [Related]
12. NMR Reveals the Interplay among the AMSH SH3 Binding Motif, STAM2, and Lys63-Linked Diubiquitin.
Hologne M; Cantrelle FX; Riviere G; Guillière F; Trivelli X; Walker O
J Mol Biol; 2016 Nov; 428(22):4544-4558. PubMed ID: 27725184
[TBL] [Abstract][Full Text] [Related]
13. Lys63/Met1-hybrid ubiquitin chains are commonly formed during the activation of innate immune signalling.
Emmerich CH; Bakshi S; Kelsall IR; Ortiz-Guerrero J; Shpiro N; Cohen P
Biochem Biophys Res Commun; 2016 Jun; 474(3):452-461. PubMed ID: 27133719
[TBL] [Abstract][Full Text] [Related]
14. MINDY-1 Is a Member of an Evolutionarily Conserved and Structurally Distinct New Family of Deubiquitinating Enzymes.
Abdul Rehman SA; Kristariyanto YA; Choi SY; Nkosi PJ; Weidlich S; Labib K; Hofmann K; Kulathu Y
Mol Cell; 2016 Jul; 63(1):146-55. PubMed ID: 27292798
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for specific cleavage of Lys 63-linked polyubiquitin chains.
Sato Y; Yoshikawa A; Yamagata A; Mimura H; Yamashita M; Ookata K; Nureki O; Iwai K; Komada M; Fukai S
Nature; 2008 Sep; 455(7211):358-62. PubMed ID: 18758443
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure and activity-based labeling reveal the mechanisms for linkage-specific substrate recognition by deubiquitinase USP9X.
Paudel P; Zhang Q; Leung C; Greenberg HC; Guo Y; Chern YH; Dong A; Li Y; Vedadi M; Zhuang Z; Tong Y
Proc Natl Acad Sci U S A; 2019 Apr; 116(15):7288-7297. PubMed ID: 30914461
[TBL] [Abstract][Full Text] [Related]
17. CaMKII mediates recruitment and activation of the deubiquitinase CYLD at the postsynaptic density.
Thein S; Tao-Cheng JH; Li Y; Bayer KU; Reese TS; Dosemeci A
PLoS One; 2014; 9(3):e91312. PubMed ID: 24614225
[TBL] [Abstract][Full Text] [Related]
18. Five new CYLD mutations in skin appendage tumors and evidence that aspartic acid 681 in CYLD is essential for deubiquitinase activity.
Almeida S; Maillard C; Itin P; Hohl D; Huber M
J Invest Dermatol; 2008 Mar; 128(3):587-93. PubMed ID: 17851586
[TBL] [Abstract][Full Text] [Related]
19. Mms2-Ubc13 covalently bound to ubiquitin reveals the structural basis of linkage-specific polyubiquitin chain formation.
Eddins MJ; Carlile CM; Gomez KM; Pickart CM; Wolberger C
Nat Struct Mol Biol; 2006 Oct; 13(10):915-20. PubMed ID: 16980971
[TBL] [Abstract][Full Text] [Related]
20. Update of cylindromatosis gene (CYLD) mutations in Brooke-Spiegler syndrome: novel insights into the role of deubiquitination in cell signaling.
Blake PW; Toro JR
Hum Mutat; 2009 Jul; 30(7):1025-36. PubMed ID: 19462465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
